Reyes Arranz

Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Rafael F. Duarte, Carmen Canals, Francesco Onida et al. · Journal of Clinical Oncology · 2010 · 202 citations · Full text

Frontline autologous stem cell transplantation in high‐risk peripheral T‐cell lymphoma: a prospective study from The Gel‐Tamo Study Group

José Rodríguez, Eulogio Conde, Antonio Gutiérrez et al. · European Journal Of Haematology · 2007 · 160 citations

Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative Protocol

Iván Alvarez, Anna Sureda, Marı́a Dolores Caballero et al. · Biology of Blood and Marrow Transplantation · 2006 · 140 citations

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 132 citations

Hematological Malignancy, Frontline Bortezomib, Lymphoid Neoplasia +13

Reduced‐intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long‐term outcomes

Karl S. Peggs, Anna Sureda, Wendi Qian et al. · British Journal of Haematology · 2007 · 105 citations · Full text